Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ · Healthcare
Madrigal Pharmaceuticals, Inc. annual/quarterly revenue history and growth rate from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Madrigal Pharmaceuticals, Inc. revenue for the quarter ending March 31, 2026 was 311.3 M, a 126.84% increase year-over-year.
- Madrigal Pharmaceuticals, Inc. revenue for the twelve months ending March 31, 2026 was 948.7 M, a 1135.02% increase year-over-year.
- Madrigal Pharmaceuticals, Inc. annual revenue for 2025 was 958.4 M, a 432.05% increase from 2024.
- Madrigal Pharmaceuticals, Inc. annual revenue for 2024 was 180.1 M.
- Madrigal Pharmaceuticals, Inc. annual revenue for 2023 was 0.
- Madrigal Pharmaceuticals, Inc. annual revenue for 2022 was 0.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Madrigal Pharmaceuticals, Inc. Market Cap — FAQ
Madrigal Pharmaceuticals, Inc. (MDGL) market cap over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MDGL's market cap history?
The chart and table above show Madrigal Pharmaceuticals, Inc.'s market cap by year and by quarter, including the growth rate.